Canada's Drug Agency (CDA; French: L’Agence des médicaments du Canada, AMC) is a pan-Canadian health organization responsible for coordinating and aligning drug policy across provinces and territories. The CDA provides Canada's various healthcare organizations with evidence-based advice, allowing them to make informed choices about drug, health technology, and health system policies, in collaboration with international partners.[1]
History
editThe CDA's predecessor, the Canadian Coordinating Office for Health Technology Assessment (CCOHTA), was established in 1989 by the federal government in partnership with the provinces and territories.[2] In 2006, the organization became the Canadian Agency for Drugs and Technologies in Health (CADTH).[3][4]
The limited scope of the CADTH, which was primarily concerned with technical expertise, proved ineffective at handling issues of inadequate infrastructure, poor return on investment, duplication of resources, and above all, "fragmentation" in the country's pharmaceutical system. As part of an effort to resolve these problems and improve coordination, for example by standardizing the collection of pharmaceutical data, the federal government established the Canadian Drug Agency Transition Office (CDATO) in 2021. Its mandate was to help transition the CADTH into a new organization, the CDA, which would absorb and "build on CADTH's existing mandate and functions."[5][6]
CADTH was officially transitioned into the CDA on May 1, 2024,[7] with the federal government allocating $89.5 million over the next five years to its continued development.[8]
See also
editReferences
edit- ^ https://www.cadth.ca/about-us
- ^ "About CADTH". CADTH. Archived from the original on 6 October 2017. Retrieved 6 October 2017.
- ^ "CADTH History". CADTH. Archived from the original on 6 October 2017. Retrieved 6 October 2017.
- ^ "Pharmaceutical HTA and Reimbursement Processes – Canada". ispor.org. Archived from the original on 22 July 2018. Retrieved 22 July 2018.
- ^ "Canadian Drug Agency Transition Office". www.canada.ca. 21 February 2023. Archived from the original on 3 January 2024. Retrieved 3 January 2024.
- ^ Government of Canada, Department of Finance (19 March 2019). "Budget 2019: Home". www.budget.canada.ca. Archived from the original on 10 February 2024. Retrieved 3 January 2024.
- ^ "CADTH to Transform into Canada's Drug Agency". Pharma In Brief. 6 May 2024. Archived from the original on 8 July 2024. Retrieved 8 July 2024.
- ^ Canada, Health (18 December 2023). "The Government of Canada announces the creation of the Canadian Drug Agency". www.canada.ca. Archived from the original on 25 March 2024. Retrieved 3 January 2024.
External links
edit- CADTH — Canada
- BC Health Technology Assessment — British Columbia
- Ontario Health Technology Advisory Committee (OHTAC) — Ontario
- Institut national d'excellence en santé et en services sociaux (INESSS) — Quebec
- Contextualized Health Research Synthesis Program (CHRSP) — Newfoundland
- Drug Evaluation Alliance of Nova Scotia (DEANS) — Maritimes
- Other HTA organizations in Canada
- Another list of HTA organizations in Canada
- International Network of Agencies for Health Technology Assessment
 | This article about an organization in Canada is a stub. You can help Wikipedia by expanding it. |